Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela McHugh

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Australasian Journal of Dermatology|October 16, 2008
Nodular granulomatous phlebitis: a phlebitic tuberculidAngela McHugh, Gregory Siller, Richard Williamson, et al.
Oncotarget|May 26, 2018
Targeting the spliceosome for cutaneous squamous cell carcinoma therapy: a role for c-MYC and wild-type p53 in determining the degree of tumour selectivityLydia A Hepburn, Angela McHugh, Kenneth Fernandes, et al.
Oncotarget|May 15, 2018
Preclinical comparison of proteasome and ubiquitin E1 enzyme inhibitors in cutaneous squamous cell carcinoma: the identification of mechanisms of differential sensitivityAngela McHugh, Kenneth Fernandes, Andrew P South, et al.
The Journal of Investigative Dermatology|November 10, 2019
The Identification of Potential Therapeutic Targets for Cutaneous Squamous Cell CarcinomaAngela McHugh, Kenneth Fernandes, Nerime Chinner, et al.
The Journal of Investigative Dermatology|February 15, 2013
Methylated tissue factor pathway inhibitor 2 (TFPI2) DNA in serum is a biomarker of metastatic melanomaCristiana Lo Nigro, Hexiao Wang, Angela McHugh, et al.
The Journal of Investigative Dermatology|March 26, 2014
NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesisAndrew P South, Karin J Purdie, Stephen A Watt, et al.
Nature Communications|August 26, 2016
Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinomaPatrizia Cammareri, Aidan M Rose, David F Vincent, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Australasian Journal of Dermatology|October 16, 2008
Nodular granulomatous phlebitis: a phlebitic tuberculidAngela McHugh, Gregory Siller, Richard Williamson, et al.
Oncotarget|May 26, 2018
Targeting the spliceosome for cutaneous squamous cell carcinoma therapy: a role for c-MYC and wild-type p53 in determining the degree of tumour selectivityLydia A Hepburn, Angela McHugh, Kenneth Fernandes, et al.
Oncotarget|May 15, 2018
Preclinical comparison of proteasome and ubiquitin E1 enzyme inhibitors in cutaneous squamous cell carcinoma: the identification of mechanisms of differential sensitivityAngela McHugh, Kenneth Fernandes, Andrew P South, et al.
The Journal of Investigative Dermatology|November 10, 2019
The Identification of Potential Therapeutic Targets for Cutaneous Squamous Cell CarcinomaAngela McHugh, Kenneth Fernandes, Nerime Chinner, et al.
The Journal of Investigative Dermatology|February 15, 2013
Methylated tissue factor pathway inhibitor 2 (TFPI2) DNA in serum is a biomarker of metastatic melanomaCristiana Lo Nigro, Hexiao Wang, Angela McHugh, et al.
The Journal of Investigative Dermatology|March 26, 2014
NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesisAndrew P South, Karin J Purdie, Stephen A Watt, et al.
Nature Communications|August 26, 2016
Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinomaPatrizia Cammareri, Aidan M Rose, David F Vincent, et al.
Pageof 1